Page 5 - Ariel Hurley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ariel hurley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ariel Hurley Today - Breaking & Trending Today

$39.94 Million in Sales Expected for Blueprint Medicines Co. (NASDAQ:BPMC) This Quarter

Wall Street analysts expect Blueprint Medicines Co. (NASDAQ:BPMC – Get Rating) to post $39.94 million in sales for the current fiscal quarter, according to Zacks. Eight analysts have made estimates for Blueprint Medicines’ earnings, with the lowest sales estimate coming in at $30.90 million and the highest estimate coming in at $53.00 million. Blueprint Medicines […] ....

United States , Stifel Nicolaus , Ariel Hurley , Jeffreyw Albers , Blueprint Medicines Corporation , Asset Management Inc , Zacks Investment Research , Benjaminf Edwards Company Inc , Financial Services Group Inc , Dupont Capital Management Corp , Blueprint Medicines Co , Blueprint Medicines Company Profile Get Rating , Wall Street , Blueprint Medicines , Get Rating , Blueprint Medicine , Investment Research , Services Group , State Retirement System , Capital Management Corp , Management Inc , Medicines Company Profile , Medicines Corporation , Nasdaq Bpmc ,

Nomura Asset Management Co. Ltd. Boosts Stake in Blueprint Medicines Co. (NASDAQ:BPMC)

Nomura Asset Management Co. Ltd. raised its position in Blueprint Medicines Co. (NASDAQ:BPMC – Get Rating) by 20.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 29,935 shares of the biotechnology company’s stock after purchasing an additional 5,172 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Blueprint Medicines were worth […] ....

United States , New Jersey , Stifel Nicolaus , Ariel Hurley , Jeffreyw Albers , Blueprint Medicines Corporation , Zacks Investment Research , Jersey Common Pension Fund , Associates Corp , Nomura Asset Management Co , Financial Services Group Inc , Dupont Capital Management Corp , Blueprint Medicines Co , Nomura Asset Management , Blueprint Medicines , Get Rating , Asset Management , Services Group , State Retirement System , Capital Management Corp , Medicines Corporation , Visit Holdingschannel , Nasdaq Bpmc , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

JMP Securities Reaffirms Buy Rating for Blueprint Medicines (NASDAQ:BPMC)

Blueprint Medicines (NASDAQ:BPMC – Get Rating)‘s stock had its “buy” rating restated by research analysts at JMP Securities in a research report issued on Monday, TipRanks reports. They presently have a $152.00 price target on the biotechnology company’s stock. JMP Securities’ price objective points to a potential upside of 132.20% from the company’s previous close. […] ....

United States , Stifel Nicolaus , Ariel Hurley , Jeffreyw Albers , Morgan Stanley , Blueprint Medicines Corporation , Securities Exchange Commission , Zacks Investment Research , Ensign Peak Advisors Inc , Voya Investment Management , Dimensional Fund Advisors , Blueprint Medicines , Get Rating , Investment Research , Exchange Commission , Technologies Capital Management , Investment Management , Peak Advisors Inc , Fund Advisors , Medicines Corporation , Nasdaq Bpmc , Reiterated Rating , Jmp Securities ,

Blueprint Medicines (NASDAQ:BPMC) Shares Gap Up to $66.51

Shares of Blueprint Medicines Co. (NASDAQ:BPMC – Get Rating) gapped up before the market opened on Thursday . The stock had previously closed at $66.51, but opened at $69.23. Blueprint Medicines shares last traded at $69.03, with a volume of 551 shares trading hands. Several research analysts recently weighed in on BPMC shares. Morgan Stanley […] ....

New Zealand General , New Zealand , United States , Mark Alan Goldberg , Ariel Hurley , Morgan Stanley , Blueprint Medicines Corporation , Securities Exchange Commission , Zacks Investment Research , Norges Bank , Wellington Management Group , Marshall Wace , Blueprint Medicines Co , William Blair Investment Management , Blueprint Medicines , Get Rating , Investment Research , Exchange Commission , Director Mark Alan Goldberg , Management Group , Blair Investment Management , Medicines Corporation , Nasdaq Bpmc ,

Blueprint Medicines (NASDAQ:BPMC) Upgraded to Hold by Zacks Investment Research

Blueprint Medicines (NASDAQ:BPMC – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday, Zacks.com reports. The firm presently has a $68.00 target price on the biotechnology company’s stock. Zacks Investment Research‘s price target suggests a potential upside […] ....

United States , Stifel Nicolaus , Mark Alan Goldberg , Ariel Hurley , Asset Management North America Corp , Morgan Stanley , Blueprint Medicines Corporation , Securities Exchange Commission , Zacks Investment Research , Norges Bank , Blackrock Inc , Walleye Capital , William Blair Investment Management , Blueprint Medicines , Get Rating , Investment Research , Exchange Commission , Director Mark Alan Goldberg , Blair Investment Management , Management North America , Medicines Corporation , Nasdaq Bpmc ,